Hasija Anuj bought ABUS
March 18, 2025 · Form 4 insider transaction
Hasija Anuj bought 157,600 shares of Arbutus Biopharma Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
157,600
Price
$0.00
Total value
N/A
InsiderHasija Anuj
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 18, 2025
Filing dateMarch 20, 2025
Shares owned after157,600
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.; This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.